Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1291/week)
Manufacturing
(576/week)
Energy
(392/week)
Technology
(1125/week)
Other Manufacturing
(401/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
National Psoriasis Foundation
Jun 11, 2018
Janssen to Showcase New Data Across Broad Rheumatology Portfolio and Immunology Pipeline at EULAR 2018
Jun 05, 2018
More than 5,000 Patients Enrolled in Corrona® Psoriasis Registry
May 15, 2018
Psoriatic Arthritis Awareness Project Films Premiere during PsA Action Month
Apr 17, 2018
National Psoriasis Foundation Elects New Leaders to Board of Directors
Mar 21, 2018
Sun Pharma Announces U.S. FDA Approval of ILUMYA(TM) (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
Mar 01, 2018
New Mexico Passes Step Therapy Reform Legislation
Feb 19, 2018
AAD 2018: Treatment with Lilly's Taltz® (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity
Feb 16, 2018
New TREMFYA® (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
Feb 14, 2018
Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting
Feb 12, 2018
Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting
Dec 11, 2017
Corrona® Psoriasis Registry Expands to Canada; Enrolls First Patient
Nov 16, 2017
Global Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2017
Nov 14, 2017
National Psoriasis Foundation Launches Our Spot
Nov 08, 2017
ACR/ARHP 2017: Long-Term Use of Lilly's Taltz® (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors
Nov 07, 2017
New Phase 2 Data Show Treatment With TREMFYA® (guselkumab) Improved Psoriatic Arthritis Symptoms Through One Year
Nov 07, 2017
Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage
Oct 30, 2017
Lilly to Present New Data on Immunology Portfolio at ACR/ARHP Annual Meeting
Oct 24, 2017
Novartis collaborates with pop icon Cyndi Lauper to release new song in honor of World Psoriasis Day
Oct 23, 2017
National Psoriasis Foundation Collaborates on Treatment Comparison Research Study
Oct 16, 2017
Global Report: (Un)Happiness For Canadians With Psoriaisis Is Prevalent and Driven By Loneliness and Stress
‹‹
Page 2
››
Latest News
Aug 18, 2025
ComEd Restores Power to 80 Percent of Customers Impacted by Pair of Weekend Storms
Aug 17, 2025
Leach International Corporation Approves FDH Electronics Brand Stealth Aerospace as an Authorized Channel...
Aug 17, 2025
GVD Renovations Unveils Rocklin Kitchen & Bath Showroom for Sacramento-Area Remodels
Aug 17, 2025
Air Canada suspends plan to resume flights as union vows to continue strike
Aug 17, 2025
Air Canada cancels more flights as strike continues: statement
Aug 17, 2025
BooksRun Announces $1,000 Scholarship for Students in 2025
Aug 17, 2025
Israel says targeted Huthi energy site in Yemen
Aug 17, 2025
Iranians struggle with GPS disruption after Israel war
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events